SCHEMBL4265165

SCHEMBL4265165

O=C(O)[C@H](Cc1ccc(F)cc1)NS(=O)(=O)c1ccc(-c2ccc(-c3c(Cc4ccccc4)oc4ccccc34)cc2)cc1

nearest known ligand 0.60

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
MMP2 P08253 9/20 0.60
ADAMTS4 O75173 2/20 0.60
MMP13 P45452 2/20 0.60
MMP14 P50281 2/20 0.60
MMP9 P14780 5/20 0.59
PTPN1 P18031 10/20 0.55
PTPRF P10586 1/20 0.55
PTPRA P18433 1/20 0.55
PTPN7 P35236 1/20 0.55
DUSP3 P51452 1/20 0.55
ADAMTS5 Q9UNA0 1/20 0.54
MMP1 P03956 1/20 0.54
MMP3 P08254 1/20 0.54
MMP7 P09237 1/20 0.54
MMP8 P22894 1/20 0.52
MMP12 P39900 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4265160 1.00 MMP2 (0.60) MMP2ADAMTS4MMP13MMP14MMP9
SCHEMBL4271267 0.94 MMP2 (0.66) MMP2ADAMTS4MMP13MMP14MMP9
SCHEMBL4271261 0.94 MMP2 (0.66) MMP2ADAMTS4MMP13MMP14MMP9
SCHEMBL4273033 0.91 MMP2 (0.56) MMP2ADAMTS4MMP13MMP14MMP9
SCHEMBL4273027 0.91 MMP2 (0.56) MMP2ADAMTS4MMP13MMP14MMP9
SCHEMBL5766794 0.89 PTPN1 (0.54) MMP2ADAMTS4MMP13MMP14PTPN1
SCHEMBL5767364 0.86 PTPN1 (0.51) MMP2ADAMTS4MMP13MMP14PTPN1
SCHEMBL4265329 0.86 PTPN1 (0.57) MMP2ADAMTS4MMP13MMP14MMP9
SCHEMBL4263270 0.85 PTPN1 (0.54) MMP2ADAMTS4MMP13MMP14MMP9
SCHEMBL4263267 0.85 PTPN1 (0.54) MMP2ADAMTS4MMP13MMP14MMP9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090082392-A1 Substituted Carboxylic Acids THE INSTITUTES FOR PHARMACEUTICAL DISCOVERY LLC 2009-03-26 US claimed
US-20040266788-A1 Substituted carboxylic acids THE INSTITUTE FOR PHARMACEUTICAL DISCOVERY LLC 2004-12-30 US claimed
US-20090082392-A1 Substituted Carboxylic Acids THE INSTITUTES FOR PHARMACEUTICAL DISCOVERY LLC 2009-03-26 US disclosed
US-7358364-B2 treatment of diabetes and/or cancer; useful in the treatment of syndrome X; capable of inhibiting Protein tyrosine phosphatase THE INSTITUTE FOR PHARMACEUTICAL DISCOVERY LLC (US) 2008-04-15 US disclosed
US-20040266788-A1 Substituted carboxylic acids THE INSTITUTE FOR PHARMACEUTICAL DISCOVERY LLC 2004-12-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040266788-A1 Substituted carboxylic acids PTP4A1, PTPRS, G6PC1 MMP2 3873/4885ADAMTS4 4593/4885MMP13 4092/4885
US-20090082392-A1 Substituted Carboxylic Acids PTPRJ, PTPRS, PTPRG MMP2 3614/4885ADAMTS4 4500/4885MMP13 4095/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.